Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reference glycan structure libraries of primary human cardiomyocytes and pluripotent stem cell-derived cardiomyocytes reveal cell-type and culture stage-specific glycan phenotypes. | J Mol Cell Cardiol | 2020 | 31972267 | PubTator, text mining | PubMed |
| Role of Cyclosporine in Gingival Hyperplasia: An In Vitro Study on Gingival Fibroblasts. | Int J Mol Sci | 2020 | 31963361 | PubTator, text mining | PubMed |
| Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling. | Life Sci Alliance | 2020 | 31959624 | PubTator, text mining | PubMed |
Trophoblast cell differentiation in the bovine placenta: differentially expressed genes between uninucleate trophoblast cells and trophoblast giant cells are involved in the composition and remodeling of the extracellular matrix and O-glycan biosynthesis. | BMC Mol Cell Biol | 2020 | 31952476 | PubTator, text mining | PubMed |
| Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy. | Nat Commun | 2020 | 31949166 | PubTator, text mining | PubMed |
| Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. | J Neuroinflammation | 2020 | 31937331 | PubTator, text mining | PubMed |
| A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report. | Biomed Rep | 2020 | 31929873 | PubTator, text mining | PubMed |
| NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. | Mol Oncol | 2020 | 31854063 | PubTator, text mining | PubMed |
| biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies. | Mol Ther | 2020 | 31843448 | PubTator, text mining | PubMed |
| Insights into the genetic basis of retinal detachment. | Hum Mol Genet | 2020 | 31816047 | PubTator, text mining | PubMed |
| Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research. | Semin Cancer Biol | 2020 | 31689495 | PubTator, text mining | PubMed |
| An EMT-related gene signature for the prognosis of human bladder cancer. | J Cell Mol Med | 2020 | 31657881 | PubTator, text mining | PubMed |
| Bioactive fragments of laminin and collagen chains: lesson from the testis. | Reproduction | 2020 | 31581125 | PubTator, text mining | PubMed |
| Skeletal muscle: A review of molecular structure and function, in health and disease. | Wiley Interdiscip Rev Syst Biol Med | 2020 | 31407867 | PubTator, text mining | PubMed |
| Extracellular matrix-derived biomaterials in engineering cell function. | Biotechnol Adv | 2020 | 31381963 | PubTator, text mining | PubMed |
| Mix and (mis-)match - The mechanosensing machinery in the changing environment of the developing, healthy adult and diseased heart. | Biochim Biophys Acta Mol Cell Res | 2020 | 30742931 | PubTator, text mining | PubMed |
| LAMC1, LAMA2 and LAMA3 gene polymorphisms and the risk for severe pelvic organ prolapse. | Sci Bull (Beijing) | 2019 | 36659797 | PubTator, text mining | PubMed |
| Generalized Score Matching for Non-Negative Data. | J Mach Learn Res | 2019 | 34290571 | PubTator, text mining | PubMed |
| Discovery of rare variants implicated in schizophrenia using next-generation sequencing. | J Transl Genet Genom | 2019 | 33981965 | PubTator, text mining | PubMed |
| Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy. | Emerg Top Life Sci | 2019 | 33523194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=49